What is the current France In-Vitro Diagnostics Market size?

The France In-Vitro Diagnostics Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029) Read More

Who are the key players in France In-Vitro Diagnostics Market?

Thermo Fischer Scientific Inc, QIAGEN N.V., Siemens Healthcare GmbH, F. Hoffmann-La Roche AG and Abbott Laboratories are the major companies operating in the France In-Vitro Diagnostics Market. Read More

What years does this France In-Vitro Diagnostics Market cover?

The report covers the France In-Vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the France In-Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

In Vitro Diagnostics Market in France

In Vitro Diagnostics Market in France Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers France IVD Market Segmentation & Companies and the market is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, and Other Techniques), Product (Instrument, Reagent, and Other Products), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, and Other Applications) and End-users (Diagnostic Laboratories, Hospitals, and Clinics and Other End-users). The market provides the value (in USD million) for the above-mentioned segments.

France In-Vitro Diagnostics Industry Overview

France is a developed region with a well-structured healthcare system. As a result, many players in the in-vitro diagnostics market are present in the country. Thus, the in-vitro diagnostic market in France is fairly fragmented, with the presence of local players competing in the market. Some of the players in the market include Abbott Laboratories, F. Hoffmann-La Roche AG, QIAGEN N.V., Siemens Healthineers AG, Thermo Fischer Scientific Inc., BioMerieux and Becton, Dickinson and Company.